Filing Flows › Strata Critical Medical (SRTA) › Q2 2025
Strata Critical Medical (SRTA) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 5, 2025
Strata Critical Medical (SRTA) reported revenue of $70.8M for the second quarter 2025 (Q2 2025), +4% from a year earlier and +30% from the quarter before. Operating margin was -7.0%, net loss $3.7M (5.3% of revenue).
Strata Critical Medical, Q2 2025: revenue $70.8M (+4% year over year), operating margin -7.0%, net loss $3.7M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $70.8M | +30% | +4% |
| Operating profit | −$5.0M | — | — |
| Net earnings | −$3.7M | — | — |
| Operating cash flow | −$3.1M | — | — |
What changed
Revenue was $70.8M in Q2 2025, up 4% year over year and up 30% from the previous quarter.
Gross margin was 12.7%. Operating costs exceeded revenue by $5.0M, an operating margin of -7.0%. The quarter ended with a net loss of $3.7M, wider than the previous quarter's $3.5M loss. Non-operating items added $1.2M, -33% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$3.1M. Non-cash charges added back $1.8M of depreciation and amortization and $5.3M of share-based compensation. Working capital and other items used $6.4M. Capital expenditures of $2.2M exceeded it, leaving free cash flow of −$5.3M.
Questions
What was Strata Critical Medical's revenue in the second quarter 2025?
Strata Critical Medical (SRTA) reported revenue of $70.8M for the second quarter 2025 (Q2 2025), +4% from a year earlier and +30% from the quarter before.
Was Strata Critical Medical profitable in the second quarter 2025?
Operating loss was $5.0M (-7.0% of revenue) and net loss $3.7M.